Pharmaceutical Technology Europe
In drug development, the majority of new chemical entities are lipophilic and/or poorly soluble. New actives often fail during development due to these challenging properties.
Dr Ralph Fink
Advertisement
Dr. Ralf Fink is Vice-President of Global Marketing, BASF Pharma Ingredients & Services.
Articles by Dr Ralph Fink
Advertisement
Latest Updated Articles
Collaborative Work can Lead to InnovationSeptember 2nd 2012
Advertisement
Advertisement